Report Detail

Request for Sample of this report

Pharma & Healthcare Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Monoclonal Antibodies Market 2018, Forecast to 2023

  • RnM2743926
    • |
  • 10 February, 2020
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Market Overview
The global Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Monoclonal Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Monoclonal Antibodies market has been segmented into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

By Application, Monoclonal Antibodies has been segmented into:
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Monoclonal Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level Monoclonal Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monoclonal Antibodies market.

The report offers in-depth assessment of the growth and other aspects of the Monoclonal Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Monoclonal Antibodies Market Share Analysis
Monoclonal Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Monoclonal Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monoclonal Antibodies sales, revenue and market share for each player covered in this report.

The major players covered in Monoclonal Antibodies are:
AbbVie
Formation Biologics
Amgen
Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
BMS
Merck
Genmab
Pfizer
Synthon Biopharmaceuticals
Human Genome Sciences
Teva
Seattle Genetics
Novartis
mmunogen
Takeda
Stemcentrx
MedImmune

Among other players domestic and global, Monoclonal Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Monoclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Monoclonal Antibodies, with price, sales, revenue and global market share of Monoclonal Antibodies in 2018 and 2019.
Chapter 3, the Monoclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Monoclonal Antibodies Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Cancer
      • 1.2.3 Autoimmune Diseases
      • 1.2.4 Infection
      • 1.2.5 Hematological Diseases
      • 1.2.6 Others
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Oncology
      • 1.3.3 Autoimmune and inflammatory diseases
      • 1.3.4 Respiratory diseases
      • 1.3.5 Ophthalmology
    • 1.4 Overview of Global Monoclonal Antibodies Market
      • 1.4.1 Global Monoclonal Antibodies Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 AbbVie
      • 2.1.1 AbbVie Details
      • 2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 AbbVie SWOT Analysis
      • 2.1.4 AbbVie Product and Services
      • 2.1.5 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Formation Biologics
      • 2.2.1 Formation Biologics Details
      • 2.2.2 Formation Biologics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Formation Biologics SWOT Analysis
      • 2.2.4 Formation Biologics Product and Services
      • 2.2.5 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Amgen
      • 2.3.1 Amgen Details
      • 2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Amgen SWOT Analysis
      • 2.3.4 Amgen Product and Services
      • 2.3.5 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Roche
      • 2.4.1 Roche Details
      • 2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Roche SWOT Analysis
      • 2.4.4 Roche Product and Services
      • 2.4.5 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Eli Lilly
      • 2.5.1 Eli Lilly Details
      • 2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Eli Lilly SWOT Analysis
      • 2.5.4 Eli Lilly Product and Services
      • 2.5.5 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Johnson & Johnson
      • 2.6.1 Johnson & Johnson Details
      • 2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Johnson & Johnson SWOT Analysis
      • 2.6.4 Johnson & Johnson Product and Services
      • 2.6.5 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 GlaxoSmithKline
      • 2.7.1 GlaxoSmithKline Details
      • 2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 GlaxoSmithKline SWOT Analysis
      • 2.7.4 GlaxoSmithKline Product and Services
      • 2.7.5 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 BMS
      • 2.8.1 BMS Details
      • 2.8.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 BMS SWOT Analysis
      • 2.8.4 BMS Product and Services
      • 2.8.5 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Merck
      • 2.9.1 Merck Details
      • 2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Merck SWOT Analysis
      • 2.9.4 Merck Product and Services
      • 2.9.5 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Genmab
      • 2.10.1 Genmab Details
      • 2.10.2 Genmab Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Genmab SWOT Analysis
      • 2.10.4 Genmab Product and Services
      • 2.10.5 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Pfizer
      • 2.11.1 Pfizer Details
      • 2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Pfizer SWOT Analysis
      • 2.11.4 Pfizer Product and Services
      • 2.11.5 Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Synthon Biopharmaceuticals
      • 2.12.1 Synthon Biopharmaceuticals Details
      • 2.12.2 Synthon Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Synthon Biopharmaceuticals SWOT Analysis
      • 2.12.4 Synthon Biopharmaceuticals Product and Services
      • 2.12.5 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Human Genome Sciences
      • 2.13.1 Human Genome Sciences Details
      • 2.13.2 Human Genome Sciences Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Human Genome Sciences SWOT Analysis
      • 2.13.4 Human Genome Sciences Product and Services
      • 2.13.5 Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Teva
      • 2.14.1 Teva Details
      • 2.14.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Teva SWOT Analysis
      • 2.14.4 Teva Product and Services
      • 2.14.5 Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Seattle Genetics
      • 2.15.1 Seattle Genetics Details
      • 2.15.2 Seattle Genetics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Seattle Genetics SWOT Analysis
      • 2.15.4 Seattle Genetics Product and Services
      • 2.15.5 Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 Novartis
      • 2.16.1 Novartis Details
      • 2.16.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 Novartis SWOT Analysis
      • 2.16.4 Novartis Product and Services
      • 2.16.5 Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.17 mmunogen
      • 2.17.1 mmunogen Details
      • 2.17.2 mmunogen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.17.3 mmunogen SWOT Analysis
      • 2.17.4 mmunogen Product and Services
      • 2.17.5 mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.18 Takeda
      • 2.18.1 Takeda Details
      • 2.18.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.18.3 Takeda SWOT Analysis
      • 2.18.4 Takeda Product and Services
      • 2.18.5 Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.19 Stemcentrx
      • 2.19.1 Stemcentrx Details
      • 2.19.2 Stemcentrx Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.19.3 Stemcentrx SWOT Analysis
      • 2.19.4 Stemcentrx Product and Services
      • 2.19.5 Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.20 MedImmune
      • 2.20.1 MedImmune Details
      • 2.20.2 MedImmune Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.20.3 MedImmune SWOT Analysis
      • 2.20.4 MedImmune Product and Services
      • 2.20.5 MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Monoclonal Antibodies Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Monoclonal Antibodies Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Monoclonal Antibodies Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 4.3 Europe Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 4.5 South America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Monoclonal Antibodies Sales, Revenue and Market Share by Country
      • 5.1.1 North America Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 5.3 Canada Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 6.3 UK Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 6.4 France Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 6.5 Russia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 6.6 Italy Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 7.3 Japan Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 7.4 Korea Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 7.5 India Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 7.7 Australia Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Monoclonal Antibodies Sales, Revenue and Market Share by Country
      • 8.1.1 South America Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Monoclonal Antibodies Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Monoclonal Antibodies Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Monoclonal Antibodies Sales and Market Share by Type (2015-2020)
    • 10.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Monoclonal Antibodies Price by Type (2015-2020)

    11 Global Monoclonal Antibodies Market Segment by Application

    • 11.1 Global Monoclonal Antibodies Sales Market Share by Application (2015-2020)
    • 11.2 Global Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
    • 11.3 Global Monoclonal Antibodies Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Monoclonal Antibodies Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Monoclonal Antibodies Market Forecast (2021-2025)
      • 12.2.2 Europe Monoclonal Antibodies Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Monoclonal Antibodies Market Forecast (2021-2025)
      • 12.2.4 South America Monoclonal Antibodies Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Monoclonal Antibodies Market Forecast (2021-2025)
    • 12.3 Monoclonal Antibodies Market Forecast by Type (2021-2025)
      • 12.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
    • 12.4 Monoclonal Antibodies Market Forecast by Application (2021-2025)
      • 12.4.1 Global Monoclonal Antibodies Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Monoclonal Antibodies Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Monoclonal Antibodies . Industry analysis & Market Report on Monoclonal Antibodies is a syndicated market report, published as Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Monoclonal Antibodies Market 2018, Forecast to 2023. It is complete Research Study and Industry Analysis of Monoclonal Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo